1,181 results on '"SOFFIETTI, RICCARDO"'
Search Results
52. Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial
53. Contributors List
54. Evidence-based approaches to chemotherapy for gliomas
55. The early recognition and diagnosis of neoplastic meningitis
56. European Cancer Organisation Essential Requirements for Quality Cancer Care: Adult glioma
57. Brain Metastasis as Complication of Systemic Cancers
58. Long-term survival of a sacro-coccygeal myxopapillary ependymoma with extra-neural metastases: case report and review of the literature
59. The Evolving Landscape of Brain Metastasis
60. Where are we now? And where are we going? A report from the Accelerate Brain Cancer Cure (ABC2) low-grade glioma research workshop.
61. Histology and Anatomic Site in Ependymoma
62. Efficacy of initial temozolomide for high-risk low grade gliomas in a phase II AINO (Italian Association for Neuro-Oncology) study: a post-hoc analysis within molecular subgroups of WHO 2016
63. Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group
64. Natural History and Spontaneous Prognostic Factors
65. CNSC-16. MOLECULAR PROFILING AND ACTIONABLE MUTATIONS IN ADULT PATIENTS WITH IDH WILD TYPE GLIOMAS AND GLIONEURONAL AND NEURONAL TUMORS
66. RTID-02. SILMET TRIAL: A RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE SILIBININ IN PREVENTING INTRACRANIAL RECURRENCE AFTER COMPLETE RESECTION OF A SINGLE BRAIN METASTASIS FROM NSCLC OR BREAST CANCER
67. QOL-26. A RANDOMIZED, DOUBLE-BLIND PHASE 3 STUDY OF VORASIDENIB VS PLACEBO IN PATIENTS WITH MUTANT IDH1/2DIFFUSE GLIOMA (INDIGO): ANALYSIS OF HEALTH-RELATED QUALITY OF LIFE, NEUROCOGNITION AND SEIZURES
68. CTNI-51. A RANDOMIZED DOUBLE-BLIND PHASE 3 STUDY OF VORASIDENIB VS PLACEBO IN PATIENTS WITH MUTANT IDH1/2 DIFFUSE GLIOMA (INDIGO): EXPLORATORY ANALYSIS OF VARIANT ALLELE FREQUENCY AND PROGRESSION-FREE SURVIVAL
69. Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
70. Identifying critical steps towards improved access to innovation in cancer care: a European CanCer Organisation position paper
71. European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas
72. EANO - EURACAN - SNO Guidelines on circumscribed astrocytic gliomas, glioneuronal, and neuronal tumors
73. The 2022 European postgraduate (residency) programme in neurology in a historical and international perspective.
74. Epilepsy in CNS Metastases
75. Prevention Strategies for Brain Metastasis
76. Editorial: Neuro-oncology is moving ahead: new perspectives and critical issues
77. Is chemotherapy alone an option as initial treatment for low-grade oligodendrogliomas?
78. STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis
79. BSBM-12 STAT3 EXPRESSION IN BRAIN METASTASES FROM BREAST CANCER: CORRELATIONS WITH DIFFERENT MOLECULAR SUBTYPES AND CLINICAL OUTCOME
80. Neurotoxicity from Old and New Radiation Treatments for Brain Tumors
81. Long-term survival with IDH wildtype glioblastoma: First results from the ETERNITY Brain Tumor Funders’ Collaborative Consortium (EORTC 1419).
82. EANO guidelines for the diagnosis and treatment of meningiomas
83. Strategies to prevent brain metastasis
84. Complete response of spinal metastases from non-small cell lung cancer with ALK inhibitors
85. European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL)
86. Long-term survival with IDH wildtype glioblastoma:first results from the ETERNITY Brain Tumor Funders’ Collaborative Consortium (EORTC 1419)
87. Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders’ Collaborative Consortium (EORTC 1419)
88. The early recognition and diagnosis of neoplastic meningitis.
89. Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology
90. Response assessment criteria for brain metastases: proposal from the RANO group
91. A comprehensive characterization of mitochondrial DNA mutations in glioblastoma multiforme
92. Lacosamide in patients with gliomas and uncontrolled seizures: results from an observational study
93. Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma
94. Diagnosis and treatment patterns for patients with leptomeningeal metastasis from solid tumors across Europe
95. Natural History and Spontaneous Prognostic Factors
96. The 2022 European Postgraduate (Residency) Program in Neurology in an historical and international perspective
97. Ependymomas
98. EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma
99. Perspectives of Personalized Chemotherapy of Gliomas Based on Molecular Tumor Profiling
100. Editorial: Hot Topics in Neuro-Oncology
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.